Loading company…
Riskpilot
← Back to search
Sign in
Get full access
ARENABRE AS
AS
Active
Org 929050398
Halvorstua 1, 3021 Drammen
Medical specialists activities · NACE 8622
Est. 2022
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 2,9M
+12% vs 2023
EBITDA margin
28.8%
+41% vs 2023
Equity ratio
34.3%
Financial strength
Net profit 2024
NOK 328K
+124% vs 2023
EBITDA — year on year
NOK millions
1M
1M
1M
0M
0M
0M
2022
1M
+100%
2023
1M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 2,9M
+12%
EBITDA
NOK 846K
+41%
Net profit
NOK 328K
+124%
Total assets
NOK 2M
+2%
Equity
NOK 695K
+89%
Employees
1
—
Company information
Legal name
ARENABRE AS
Org number
929050398
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
7. april 2022
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Legevirksomhet innen øyesykdommer og det som naturlig står i forbindelse med dette, samt investeringsvirksomhet og kjøp/salg av eiendom.
Contact
Address
Halvorstua 1, 3021 Drammen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Drammen
All Norway companies
Revenue
NOK millions
0M
1M
2M
3M
3M
1M
2022
3M
2023
3M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2022
1M
2023
1M
2024
Income statement
NOK thousands
Item
2022
2023
2024
Revenue
971
2 629
2 934
Staff expenses
−502
−1 969
−2 019
EBITDA
457
601
846
Depreciation & amort.
−120
−360
−360
EBIT
337
241
486
Net financials
−21
−53
−65
Profit before tax
316
187
420
Tax
68
41
93
Net profit
247
146
328
Balance sheet
NOK thousands
Item
2022
2023
2024
Total assets
1 826
1 984
2 025
Equity
272
368
695
Long-term debt
1 224
1 043
851
Short-term debt
331
572
479
Total debt
1 555
1 616
1 330
Financial ratios
5-year trend
EBITDA margin
28.8%
This company
15.8%
Market median
+82% vs market
2022
2024
Equity ratio
34.3%
This company
38.2%
Market median
+10% vs market
2022
2024
Return on equity
47.1%
This company
18.4%
Market median
+156% vs market
2022
2024
Net profit margin
11.2%
This company
8.1%
Market median
+38% vs market
2022
2024
Asset turnover
1.45×
This company
1.12×
Market median
+29% vs market
2022
2024
Debt / equity
1.91×
This company
0.62×
Market median
-208% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-03-09 – 2022-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
AP
Aleksandar Pavlovic
Chief Executive Officer
Chief Executive Officer
2022
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
ARENABRE AS
(this company)
SANDVIKA ØYELEGESENTER AS
Board network connections
Board members of ARENABRE AS also hold positions in
0
other companies.
Person
Role here
Other companies
Aleksandar Pavlovic
Chief Executive Officer
0 companies